Talar R Moukhtarian

Dr. Talar R Moukhtarian

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in European Psychiatry
Verified
Journal Article
Open access
TMTalar R Moukhtarian
Talar R Moukhtarian
RCR.E. Cooper
R.E. Cooper
EVE. Vassos
E. Vassos
PMP. Moran
P. Moran
PAP. Asherson
P. Asherson
Background: Emotional lability (EL) is an associated feature of attention-deficit/hyperactivity disorder (ADHD) in adults, contributing to functional impairment. Yet the effect of pharmacological treatments for ADHD on EL symptoms is unknown. We conducted a systematic review and meta-analysis to examine the effects of stimulants and atomoxetine on symptoms of EL and compare these with the effects on core ADHD symptoms.Methods: A systematic search was conducted on the databases Embase, PsychInfo, and Ovid Medline®and the clinicaltrials.gov website. We included randomised, double-blind, placebo-controlled trials of stimulants and atomoxetine in adults aged 18–60 years, with any mental health diagnosis characterised by emotional or mood instability, with at least one outcome measure of EL. All identified trials were on adults with ADHD. A random-effects meta-analysis with standardised mean difference and 95% confidence intervals was used to investigate the effect size on EL and compare this to the effect on core ADHD symptoms.Results: Of the 3,864 publications identified, nine trials met the inclusion criteria for the meta-analysis. Stimulants and atomoxetine led to large mean weighted effect-sizes for on ADHD symptoms (n= 9, SMD = −0.8, 95% CI:−1.07 to −0.53). EL outcomes showed more moderate but definite effects (n= 9, SMD = −0.41, 95% CI:−0.57 to −0.25).Conclusions: In this meta-analysis, stimulants and atomoxetine were moderately effective for EL symptoms, while effect size on core ADHD symptoms was twice as large. Methodological issues may partially explain the difference in effect size. Reduced average effect size could also reflect heterogeneity of EL with ADHD pharmacotherapy responsive and non-responsive sub-types. Our findings indicate that EL may be less responsive than ADHD symptoms overall, perhaps indicating the need for adjunctive psychotherapy in some cases. To clarify these questions, our findings need replication in studies selecting subjects for high EL and targeting EL as the primary outcome.

20 May 2018 in Borderline Personality Disorder and Emotion Dysregulation
Verified
Journal Article
Open access
PDF file
TMTalar R Moukhtarian
Talar R Moukhtarian
RMRuth S. Mintah
Ruth S. Mintah
PMPaul Moran
Paul Moran
PAPhilip Asherson
Philip Asherson
There is ongoing debate on the overlap between Attention-Deficit/Hyperactivity Disorder (ADHD) and Borderline Personality Disorder (BPD), particularly regarding emotion dysregulation (ED). In this paper, we present a narrative review of the available evidence on the association of these two disorders from several standpoints. First, we discuss the unique and shared diagnostic criteria for ADHD and BPD, focusing particularly on ED. We consider the methodology of ecological momentary assessment and discuss why this approach could be an alternative and more accurate way to qualitatively distinguish between ADHD and BPD. We summarise key findings on the genetic and environmental risk factors for ADHD and BPD and the extent to which there are shared or unique aetiological and neurobiological risk factors. Finally, we discuss the clinical relevance of considering both disorders in the assessment of patients presenting with trait-like behavioural syndromes, distinguishing the two conditions and implications for treatment.

1 August 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
EKElena D. Koch
Elena D. Koch
TMTalar R Moukhtarian
Talar R Moukhtarian
CSCaroline Skirrow
Caroline Skirrow
NBNatali Bozhilova
Natali Bozhilova
PAPhilip Asherson
Philip Asherson
UEUlrich W. Ebner-Priemer
Ulrich W. Ebner-Priemer

8 February 2024 in Frontiers in Sleep
Verified
Journal Article
Open access
Amber Francesca ToutAmber Francesca Tout
Amber Francesca Tout
NTNicole K. Y. Tang
Nicole K. Y. Tang
TSTracey L. Sletten
Tracey L. Sletten
CTCarla T. Toro
Carla T. Toro
CKCharlotte Kershaw
Charlotte Kershaw
TMTalar R Moukhtarian
Talar R Moukhtarian
Introduction: Shift work can lead to sleep disturbances and insomnia during the sleeping period, as well as excessive sleepiness and fatigue during the waking period. While Cognitive Behavioral Therapy (CBT-i) is recommended as the first line of treatment for insomnia, key elements of CBT-i, such as maintaining a consistent sleep schedule, can be challenging for shift workers, highlighting the need for tailored sleep interventions. This mini review provides a narrative synthesis of non-pharmacological sleep interventions for shift workers and informs the development of a preventative, multicomponent sleep management programme.Method: An informal review was conducted in line with Phase 1 of the Framework for the Development and Evaluation of Complex Interventions.Results: A variety of strategies have been employed to help manage the impacts of shift work on sleep, including: CBT-i, adjusting shift schedules, controlled light exposure, sleep hygiene education, planned napping, caffeine consumption, and mind-body interventions (e.g., yogic relaxation).Discussion: Recommendations, limitations, and directions for future research are discussed; notably, the role of the family, the commute to and from the workplace, and the eating behaviors of employees appear to have been overlooked in current intervention efforts. Digital CBT-i platforms could help to provide an effective, scalable, and low-cost method of reducing insomnia in shift workers.

12 February 2021 in Borderline Personality Disorder and Emotion Dysregulation
Verified
Journal Article
Open access
PDF file
TMTalar R Moukhtarian
Talar R Moukhtarian
IRIris Reinhard
Iris Reinhard
PMPaul Moran
Paul Moran
CRCeline Ryckaert
Celine Ryckaert
CSCaroline Skirrow
Caroline Skirrow
PAPhilip Asherson
Philip Asherson
Background: Emotional dysregulation (ED) is a core diagnostic symptom in borderline personality disorder (BPD) and an associated feature of attention-deficit/hyperactivity disorder (ADHD). We aimed to investigate differences in dynamical indices of ED in daily life in ADHD and BPD. Methods: We used experience sampling method (ESM) and multilevel modelling to assess momentary changes in reports of affective symptoms, and retrospective questionnaire measures of ED in a sample of 98 adult females with ADHD, BPD, comorbid ADHD+BPD and healthy controls. Results: We found marked differences between the clinical groups and healthy controls. However, the ESM assessments did not show differences in the intensity of feeling angry and irritable, and the instability of feeling sad, irritable and angry, findings paralleled by data from retrospective questionnaires. The heightened intensity in negative emotions in the clinical groups compared to controls was only partially explained by bad events at the time of reporting negative emotions, suggesting both reactive and endogenous influences on ED in both ADHD and BPD. Conclusions: This study supports the view that ED is a valuable trans-diagnostic aspect of psychopathology in both ADHD and BPD, with similar levels of intensity and instability. These findings suggest that the presence or severity of ED should not be used in clinical practice to distinguish between the two disorders.

1 September 2020 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
TMTalar R Moukhtarian
Talar R Moukhtarian
IRIris Reinhard
Iris Reinhard
AMAlfonso Morillas-Romero
Alfonso Morillas-Romero
CRCeline Ryckaert
Celine Ryckaert
FMFlorence Mowlem
Florence Mowlem
PAPhilip Asherson
Philip Asherson